EDITORIAL
Published on 11 Dec 2024
Editorial: Novel pathophysiologic mechanisms and reno-protective pharmacotherapies in diabetic kidney disease
doi 10.3389/fphar.2024.1531748
- 349 views
- Frontiers in Pharmacology
- Renal Pharmacology
- Research Topics
- Novel Pathophysiologic Mechanisms and Reno-protective Pharmacotherapies in Diabetic Kidney Disease
Novel Pathophysiologic Mechanisms and Reno-protective Pharmacotherapies in Diabetic Kidney Disease
6,153
Total downloads
17k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 22 Aug 2024
Sixteen prescribed Chinese herbal medicines provide time-dependent cardiorenal and survival benefits in patients with overall and advanced diabetic kidney disease: a real-world study in Taiwan
doi 10.3389/fphar.2024.1297854
- 759 views
REVIEW
Published on 31 Jul 2024
A new perspective on proteinuria and drug therapy for diabetic kidney disease
doi 10.3389/fphar.2024.1349022
- 2,132 views
- 1 citation
ORIGINAL RESEARCH
Published on 19 Jul 2024
Efficacy and safety of polyethylene glycol loxenatide in treating mild-to-moderate diabetic kidney disease in type 2 diabetes patients: a randomized, open-label, clinical trial
doi 10.3389/fendo.2024.1387993
- 1,515 views
ORIGINAL RESEARCH
Published on 12 Jun 2024
SGLT2i treatment during AKI and its association with major adverse kidney events
doi 10.3389/fphar.2024.1356991
- 1,633 views
SYSTEMATIC REVIEW
Published on 22 Apr 2024
Ophiocordyceps sinensis preparations combined with the renin–angiotensin system inhibitor for diabetic kidney disease treatment: an umbrella review of systematic reviews and network meta-analysis
doi 10.3389/fphar.2024.1360633
- 1,264 views
ORIGINAL RESEARCH
Published on 20 Mar 2024
Astragaloside IV attenuates renal tubule injury in DKD rats via suppression of CD36-mediated NLRP3 inflammasome activation
doi 10.3389/fphar.2024.1285797
- 1,511 views
- 3 citations
ORIGINAL RESEARCH
Published on 08 Jan 2024
Identification of the main flavonoids of Abelmoschus manihot (L.) medik and their metabolites in the treatment of diabetic nephropathy
doi 10.3389/fphar.2023.1290868
- 1,211 views
- 2 citations
SYSTEMATIC REVIEW
Published on 05 Jan 2024
Efficacy and safety of Abelmoschus manihot capsule combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta analysis
doi 10.3389/fphar.2023.1288159
- 2,040 views
Published in
Frontiers in Pharmacology
- Renal Pharmacology
- Ethnopharmacology
- Drug Metabolism and Transport
Impact
- 17kTopic views
- 10kArticle views
- 6,153Article downloads